Synlogic, Inc. (SYBX)
OTCMKTS · Delayed Price · Currency is USD
1.220
-0.010 (-0.81%)
At close: Aug 20, 2026
Synlogic Market Cap
Synlogic has a market cap or net worth of $14.27 million as of August 21, 2026. Its market cap has decreased by -12.87% in one year.
Market Cap
14.27M
Enterprise Value
1.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.22
ChartMarket Cap Chart
Since August 28, 2017, Synlogic's market cap has decreased from 196.53M to 14.27M, a decrease of -92.74%. That is a compound annual growth rate of -25.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 14.27M | 8.91% |
| Dec 31, 2025 | 13.10M | -19.98% |
| Dec 31, 2024 | 16.37M | -53.72% |
| Dec 29, 2023 | 35.38M | -33.99% |
| Dec 30, 2022 | 53.60M | -68.23% |
| Dec 31, 2021 | 168.70M | 124.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 25.30M |
| Provectus Biopharmaceuticals | 23.14M |
| Oncotelic Therapeutics | 18.97M |
| ZIVO Bioscience | 16.40M |
| Finch Therapeutics Group | 16.38M |
| Inhibitor Therapeutics | 15.47M |
| Anebulo Pharmaceuticals | 14.27M |
| Brainstorm Cell Therapeutics | 13.43M |